CClinicalTrials.gg
Status unknownNCT01017289Updated Nov 20, 2009

Intramedullary Fixation of Humerus Fractures

An interventional study of Quantum in Humeral Fractures and Pathological Fractures, sponsored by N.M.B. Medical Applications Ltd. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2009-11-20.

Sponsored by N.M.B. Medical Applications Ltd · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2009), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The purpose of the study is to evaluate the safety and efficacy of the composite Nail - the Quantum interlocking intramedullary nailing system in the reduction of humeral fractures.

Read the detailed description

The study will include 20 patients who have an acute mid shaft diaphyseal humeral fracture due to injury. The patients will undergo lateral and AP X- ray evaluation of the fracture. Following General anesthesia, closed reduction of the fracture will be performed. It will be followed by nail insertion, percutaneously, according to standard surgical techniques, with the help of the insertion handle. Following insertion the nail will be locked both distally and proximally using interlocking screws. The nail and screws insertion will be monitored by fluoroscopy. Patients will remain under follow up for 6 months following the procedure. In the follow up sessions the fracture will be evaluated by fluoroscopy or X-ray for correct bone alignment, callus formation, and fracture union.

02

Conditions studied

  • Humeral Fractures
  • Pathological Fractures
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 20 is below the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

N.M.B. Medical Applications Ltd is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Above 18 years old.
  • Mid shaft diaphyseal fracture
  • Acute fracture

Exclusion criteria

Exclusion Criteria:

  • Patients with metabolic or hormonal diseases that could affect bone healing such as diabetes.
  • Ongoing infection in fracture site.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Quantum

    In this single arm study, the Quantum nailing system will be used in all patients.

    Device: Quantum

Interventions

  • DeviceQuantum

    Treatment of humerus fracture (according to the mentioned indications) with the Quantum Intramedullary Nailing System.

06

What researchers measure

Primary outcomes

  1. Bone union and callus formation

    Time frame: up to 6 months

  2. Bone alignment

    Time frame: up to 6 months

  3. Nail and screws resistance over time

    Time frame: up to 6 months

07

Study locations

1 site
  • Rabin Medical Center
    Petah Tikva, 49100, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01017289
Lead sponsor
N.M.B. Medical Applications Ltd
First posted
Nov 20, 2009
Start date
Dec 2009
Primary completion
Dec 2010 (estimated)
Completion
Dec 2011 (estimated)
Last update
Nov 20, 2009

Study contacts

Michael Bernstein, Orthopedic
Contact
+972 50 544 0966
Michael Berenstein, md
principal investigator · Rabin hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion